January 19, 2016
Tallahassee, Fla. – The Associated Industries of Florida (AIF) today released the following statement attributed to its General Counsel Tamela Perdue in opposition to Senate Bill 1084, which would change the current, effective method of prior authorization, step therapy and fail-first protocols.
“AIF today opposed SB 1084 because it would negatively impact the standards of care that are currently in place and based on real-time protocols that are centered on evidence-based research. By changing the current, effective methods – which are used for the safest, most cost-effective drug and permit processing – it would force insurers and consumers to purchase the most expensive drugs and treatments even when equally effective drugs and treatments are available at much lower costs.
“AIF supports continued flexibility for health plans to ensure consumers receive high quality, high value and affordable care, through continued use of innovative plan designs to achieve this balance. AIF opposes this legislation because we believe it would only increase costs, regulation and bureaucratic red tape.”
Senate Bill 1084 has also been referred to the Senate Committee on Health Policy and Senate Appropriations.
# # #